Implications for UK practice of the use of durvalumab in stage III NSCLC
Title:
Implications for UK practice of the use of durvalumab in stage III NSCLC
Author:
Iqbal, M.S. Atherton, P. Macgregor, C. Wieczorek, A. Singer, J. Walther, J. Little, F. Harden, S. Peedell, C. Cyriac, A. Chowdhury, S. Bayne, M. Yip, K. Britten, A. Powell, C. Brock, J. Datta, S. Sevitt, T. Mehta, A. Greystoke, A.